Neopharmed Gentili SpA

Neopharmed Gentili is an Italian pharmaceutical company based in Milan. According to its official website, it is in an internationally expanding phase and specializes in the commercialization of high therapeutic value solutions, with the goal of helping people live healthy and longer lives. The company states it has 50+ years of experience in the sector, scientific information activities in 10+ therapeutic areas, and that it treated over 3 million patients in 2024. Its therapeutic areas include cardio-metabolic, vascular, pneumo-allergological, antibiotic, osteoarticular, gastro-enteric, neuro-psychiatric, otorhinolaryngological, pediatric, and urological. In September 2026 it announced the consolidation of its European rare disease activities under a single Neopharmed Gentili brand, following the October 2025 acquisition of European commercial activities for ORLADEYO (berotralstat) from BioCryst Pharmaceuticals.

Neopharmed Gentili is an Italian pharmaceutical company based in Milan. Its official website describes it as an Italian pharmaceutical company in an internationally expanding phase, specialized in the commercialization of high therapeutic value solutions, with the goal of helping people live healthy and longer lives, engaging across multiple therapeutic areas. The company reports 50+ years of experience in the sector, scientific information in 10+ therapeutic areas, and over 3 million patients treated in 2024. On 10 September 2026, Neopharmed Gentili announced the consolidation under a single brand of its European activities dedicated to rare diseases, with the renaming of companies in various countries. This operation follows the path started in October 2025 with the acquisition of the European commercial activities of ORLADEYO (berotralstat) for the treatment of hereditary angioedema (HAE) from BioCryst Pharmaceuticals.

Specialized in the commercialization of high therapeutic value solutions across multiple therapeutic areas.

1. 1Neopharmed Gentili S.p.A. | Home Page (IT)neogen.it
2. 2Neopharmed Gentili SpA (Italy)wikidata.org